RadNet Inc
NASDAQ:RDNT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.57
86.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
RadNet Inc
RadNet Inc
Cost of Revenue
RadNet Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
RadNet Inc
NASDAQ:RDNT
|
Cost of Revenue
-$1.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cost of Revenue
-$6.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cost of Revenue
-$316.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
Cost of Revenue
-$206.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cost of Revenue
-$9.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-9%
|
|
|
R1 RCM Inc
NASDAQ:RCM
|
Cost of Revenue
-$2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-27%
|
|
RadNet Inc
Glance View
RadNet Inc. stands as a formidable entity in the realm of diagnostic imaging services, charting its course as a crucial component within the broader healthcare sector. Founded in 1980, the company has evolved into a vital provider of outpatient imaging services across the United States, leveraging both organic growth and strategic acquisitions. RadNet operates a network of imaging centers, equipped with cutting-edge technology and staffed by experienced radiologists and technicians. These centers offer a range of diagnostic imaging procedures, including MRI, CT, mammography, X-ray, and ultrasound. By positioning itself at the intersection of healthcare efficiency and innovation, RadNet marries technology with patient care, optimizing the process of disease detection and diagnosis. Revenue streams for RadNet primarily flow from patient payments and insurance reimbursements for services rendered. With the increasing reliance on advanced imaging techniques in modern medicine, RadNet capitalizes on the demand for accurate, timely diagnostic data from healthcare providers aiming to enhance patient care protocols. Another key revenue avenue stems from partnerships with hospitals and healthcare systems, wherein RadNet provides the technical platform and expertise, thus enabling these institutions to focus on core patient care activities. This business model not only underscores the importance of diagnostic services in preventive and restorative healthcare but also sharpens RadNet’s competitive edge through scale, efficiency, and an extensive network of service locations.
See Also
What is RadNet Inc's Cost of Revenue?
Cost of Revenue
-1.4B
USD
Based on the financial report for Sep 30, 2024, RadNet Inc's Cost of Revenue amounts to -1.4B USD.
What is RadNet Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%
Over the last year, the Cost of Revenue growth was -10%. The average annual Cost of Revenue growth rates for RadNet Inc have been -12% over the past three years , -9% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet